General - Press Releases

Date	Title	Company
05-Jun-2023	At BIO 2023, Canada Showcases Multiple Strengths as a Biopharma Powerhouse	Businesswire
05-Jun-2023	Thermo Fisher Scientific Showcases Solutions for Accelerating Biological Discovery	Businesswire
05-Jun-2023	Thermo Fisher Scientific Introduces Groundbreaking Mass Spectrometer to Revolutionize Biological Discovery	Businesswire
05-Jun-2023	Basgenbio to Present at the BIO International Convention 2023	Businesswire
05-Jun-2023	CERo Therapeutics, Inc. and Phoenix Biotech Acquisition Corp. Announce Merger Agreement to Create Public Company Advancing the Development of Next Generation Engineered T Cell Therapeutics	Businesswire
05-Jun-2023	Charles River Laboratories to Present at William Blair and Jefferies Conferences	Businesswire
05-Jun-2023	Vaxxas Announces Interim Results from Phase I Clinical Study of First Needle-Free COVID-19 Vaccine Delivered Using Proprietary High-Density Microarray Patch (HD-MAP)	Businesswire
05-Jun-2023	Global CD137 Antibodies Clinical Trials Research Report 2023: Insights on More Than 60 CD137 Antibodies in Clinical Trials - ResearchAndMarkets.com	Businesswire
05-Jun-2023	Glaukos Achieves Pipeline Milestone with Enrollment Completion in Phase 3 Confirmatory Trial for Epioxa (Epi-on)	Businesswire
05-Jun-2023	Sarissa Urges Alkermes Shareholders to Vote the Universal Blue Card to Upgrade Alkermes for the Benefit of Shareholders	Businesswire
05-Jun-2023	Coya Therapeutics Strengthens Scientific Advisory Board (SAB) with the Addition of Neuroimmunology Pioneer, Dr. Guillaume Dorothée, an Expert on the Role of the Immune System and Regulatory T Cells (Tregs) in Alzheimer’s Disease (AD)	Businesswire
05-Jun-2023	Seres Therapeutics and Nestlé Health Science Announce U.S. Commercial Availability of VOWST™, the First and Only FDA-Approved Microbiota-Based Oral Therapeutic for Prevention of Recurrence of C. Difficile Infection	Businesswire
05-Jun-2023	Precision BioSciences to Present at Upcoming June Investor Conferences	Businesswire
05-Jun-2023	Dr. Reddy’s Successfully Completes Phase I Study (IV Route) of DRL_TC, a Proposed Biosimilar of Tocilizumab	Businesswire
05-Jun-2023	Bruker Launches timsTOF Ultra Mass Spectrometer with Transformative Sensitivity, 300 Hz PASEF MS/MS, and VistaScan™ for Enhanced dia-PASEF® 4D-Proteomics™	Businesswire
05-Jun-2023	KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Businesswire
05-Jun-2023	Bicara Therapeutics’ First-in-class Bifunctional EGFR/TGF-β Inhibitor, BCA101, Demonstrates 65% ORR in Combination with Pembrolizumab in 1L HPV-negative Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)	Businesswire
05-Jun-2023	Seneca Therapeutics, Inc. Appoints Cuong Do to its Board of Directors	Businesswire
05-Jun-2023	Sustainability as a Success Factor: OQ Chemicals Launches Biobased Oxbalance TCD Alcohol DM	Businesswire
05-Jun-2023	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire